#clinial-trial (1 Posts)
-
New Hope for Non-Hodgkin's Lymphoma Patients: Verismo's SynKIR-310 Enters Clinical Trial Phase Verismo Therapeutics, a U.S. subsidiary of HLB developing next-generation CAR-T cell therapies, announced on the 5th that it has submitted a Phase 1 clinical trial plan (IND) to the U.S. Food and Drug Administration (FDA) for SynKIR-310, a treatment for recurrent/refractory non-Hodgkin’s lymphoma. The clinical trial will target patients with various types of lymphoma, including […]
Hot Topics